Umoja Biopharma has secured $100 million in series C funds as the cancer-focused biotech looks to bring more of its cell therapies into the clinic. Umoja’s only clinical-stage candidate is UB ...

Seems like there is trouble brewing between renowned singer Guru Randhawa and music label T-Series. Guru Randhawa has hinted at his alleged fallout with T-Series after he responded to a fan on social ...